Last update 12 Dec 2024
BEY-1107P
Last update 12 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Avotaciclib, BEY-A, BEY 1107 + [3] |
Target |
Mechanism CDK1 inhibitors(Cyclin-dependent kinase 1 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC13H11N7O |
InChIKeyVFVAQKKPFOPZEA-UHFFFAOYSA-N |
CAS Registry1983983-41-0 |
Related
3
Clinical Trials associated with BEY-1107PAn Open-label, Phase I Clinical Trial to Assess the Maximum Tolerated Dose (MTD), Safety and Efficacy of BEY1107 in Combination With Temozolomide in Patient With Recurrent or Progressive Glioblastoma Multiforme (GBM)
An Open-label, Single Center, Phase I/II Clinical Trial to Assess the Maximum Tolerated Dose, Safety and Efficacy of BEY1107 in Combination With Capecitabine in Patients With Metastatic Colorectal Cancer Refractory or Intolerant to Standard of Care
A Single Center, Open-label, Non-comparative, Phase I/II Clinical Trial to Assess the MTD, Safety and Efficacy of BEY1107 in Monotherapy and in Combination With Gemcitabine in Patient With Locally Advanced or Metastatic Pancreatic Cancer
100 Clinical Results associated with BEY-1107P
Login to view more data
100 Translational Medicine associated with BEY-1107P
Login to view more data
100 Patents (Medical) associated with BEY-1107P
Login to view more data
100 Deals associated with BEY-1107P
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic Colorectal Carcinoma | Phase 2 | KR | 31 Aug 2021 | |
| Pancreatic Cancer | Phase 2 | KR | 01 May 2018 | |
| Secondary malignant neoplasm of pancreas | Phase 2 | KR | 01 May 2018 | |
| Glioblastoma Multiforme | Phase 1 | KR | 29 Nov 2022 | |
| Recurrent Glioblastoma | Phase 1 | KR | 29 Nov 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free